Billion-dollar Deals in Radiopharmaceuticals Catch Investor Attention
Recent mergers and acquisitions and partnership deals in the medical industry are showing signs of increasing investor interest in the…
81,000€
4,52%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
Imfinzi approved in US for resectable lung cancer
16 August 2024
Imfinzi approved in the US for the treatment of resectable
non-small cell lung cancer before and after surgery
Based on AEGEAN…
FDA Expands AstraZenecas (AZN) Imfinzi Label in Lung Cancer
This approval is based on late-stage study data, which shows that treatment with AstraZenecas (AZN) Imfinzi reduced the risk of…
Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal
Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.…
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several…